S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
NYSE:BMR

Biomed Realty Trust (BMR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$7.50
$8.55
50-Day Range
N/A
52-Week Range
$17.94
$25.08
Volume
2.21 million shs
Average Volume
13.80 million shs
Market Capitalization
$109.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BMR stock logo

About Biomed Realty Trust Stock (NYSE:BMR)

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.


BMR Stock News Headlines

3 Stock Winners That Are Up 400% or More in 2024
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Brandywine Realty Trust
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Boston Diversity, Equity and Inclusion News
BioMed Realty Announces 2023 ESG Achievements
Beamr Issues Q3-2023 CEO Letter to Shareholders
Biomed Reaches New 52-Week High (BMR)
Beamr Announces First Half 2023 Financial Results
See More Headlines
Receive BMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomed Realty Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/28/2015
Today
2/27/2024
Next Earnings (Estimated)
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Office REITs
CUSIP
09063H10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.86 million

Miscellaneous

Free Float
N/A
Market Cap
$109.74 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Greg N. Lubushkin (Age 62)
    Chief Financial Officer
  • James R. Berens (Age 61)
    President of Wexford Science & Technology
  • Jonathan Paul Klassen (Age 39)
    Executive Vice President, General Counsel, Secretary
  • John P. Bonanno (Age 49)
    Executive Vice President, Leasing & Development
  • Karen A. Sztraicher (Age 51)
    Executive Vice President - Asset Management














BMR Stock Analysis - Frequently Asked Questions

When is Biomed Realty Trust's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024.
View our BMR earnings forecast
.

How were Biomed Realty Trust's earnings last quarter?

Biomed Realty Trust Inc (NYSE:BMR) announced its quarterly earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.04. The real estate investment trust had revenue of $178.01 million for the quarter, compared to analyst estimates of $167.08 million. The business's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.38 earnings per share.

What other stocks do shareholders of Biomed Realty Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biomed Realty Trust investors own include Gilead Sciences (GILD), Intel (INTC), Kinder Morgan (KMI), Ventas (VTR), Verizon Communications (VZ), Welltower (WELL), Archer-Daniels-Midland (ADM), CVS Health (CVS), Dominion Energy (D) and Extra Space Storage (EXR).

When did Biomed Realty Trust IPO?

(BMR) raised $8 million in an initial public offering (IPO) on Tuesday, February 28th 2023. The company issued 1,950,000 shares at $4.00 per share.

This page (NYSE:BMR) was last updated on 2/28/2024 by MarketBeat.com Staff